id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1997-E-0063-0007,FDA,FDA-1997-E-0063,Patent Term Extension Application from Boehringer Mannheim GmbH,Other,Application,2008-11-05T05:00:00Z,2008,11,2008-11-05T05:00:00Z,,2024-09-23T19:29:24Z,,0,0,09000064805d033a
FDA-1997-E-0063-0008,FDA,FDA-1997-E-0063,"Certificate Extending Patent Term from U.S. Patent and Trademark Office to PDL Biopharma, Inc.",Other,CEP-Certificate Extending Patent Term,2008-11-05T05:00:00Z,2008,11,2008-11-05T05:00:00Z,,2024-09-23T19:32:41Z,,0,0,09000064806ac517
FDA-1997-E-0063-0006,FDA,FDA-1997-E-0063,Determination of Review Period for Purposes of Patent Extenison - RETEVASE - Federal Register Notice,Notice,General Notice,2008-11-05T05:00:00Z,2008,11,2008-11-05T05:00:00Z,2007-05-30T03:59:59Z,2024-09-23T19:28:26Z,,0,0,09000064805d033e